Invention Grant
- Patent Title: EGFR inhibitors and methods of treating disorders
-
Application No.: US13319079Application Date: 2010-05-05
-
Publication No.: US09908884B2Publication Date: 2018-03-06
- Inventor: Nathanael S. Gray , Pasi Janne , Michael J. Eck , Wenjun Zhou
- Applicant: Nathanael S. Gray , Pasi Janne , Michael J. Eck , Wenjun Zhou
- Applicant Address: US MA Boston
- Assignee: DANA-FARBER CANCER INSTITUTE, INC.
- Current Assignee: DANA-FARBER CANCER INSTITUTE, INC.
- Current Assignee Address: US MA Boston
- Agency: Swanson & Bratschun, L.L.C.
- International Application: PCT/US2010/001341 WO 20100505
- International Announcement: WO2010/129053 WO 20101111
- Main IPC: C07D403/12
- IPC: C07D403/12 ; C07D473/16 ; C07D403/14
Abstract:
The present invention relates to novel pyrimidine, pyrrolo-pyrimidine, pyrrolo-pyridine, pyridine, purine and triazine compounds which are able to modulate epidermal growth factor receptor (EGFR), including Her-kinases, and the use of such compounds in the treatment of various diseases, disorders or conditions.
Public/Granted literature
- US20120094999A1 EGFR INHIBITORS AND METHODS OF TREATING DISORDERS Public/Granted day:2012-04-19
Information query
